Presto brings smart dining to restaurants with its completely customizable guest-facing tablet. Presto Terminals enhance the guest dining experience, streamlines restaurant operations and increases a restaurant's brand value. Restaurant guests can order food, play games and pay their bill from their seats without having to wait. The Presto is both a specialized hardware and software solution designed and custom-built to fit the specific needs of restaurants. The company was founded out of MIT in 2008 and is headquartered in Silicon Valley's Redwood City. See the Presto in action here: http://ow.ly/wlxvD

Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration. For more information, please visit www.adverum.com.